Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients

Journal of Internal Medicine

Volumn 246, Issue 1, 1999, Pages 35-43

  Koga, Nobtihiko ^a,c   Watanabe, K ^a   Kurashige, Y ^a   Sato, T ^a   Hiroki, T ^b  

^a Koga Hospital   (Japan)

^b Fukuoka University Chikushi Hospital   (Japan)

^c Shin Koga Hospital   (Japan)

Author keywords

Carotid atherosclerosis; FH; LDL apheresis; Ultrasonography

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; PROBUCOL; TRIACYLGLYCEROL;

ADULT; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPID BLOOD LEVEL; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

EID: 0032795764     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.00466.x     Document Type: Article

References (21)

1. Koizurni J, Koizurni I, Uno Y, Inazu A et al. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia. Atherosclerosis 1993; 100: 65-74.
2. Gordon BR, Kelsey SF, Bilheimer DW et al. for the Liposorber Study Group. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 1992; 70: 1010-16.
3. Knisel W, Nicuolo AD, Pfohl M et al. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med 1993; 234: 479-87.
4. Tatami R, Inoue N, Itoh H et al. for the LARS Investigators. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992; 95: 1-13.
5. Nishimura S, Yamaguchi H, L-CAPS group investigators. Regression of coronary atherosclerosis by intensive lipid-lowering therapy with combined LDL-apheresis and drugs in familial hypercholesterolemia. Japan LDL-Apheresis Coronary Atherosclerosis Prospective Study (LCAPS). Circulation 1994; 90: 1-510.
6. Kroon AA, Aengevaeren WRM, van der Werf T, et al. LDL-Apheresis Atherosclerosis Regression Study (LAARS): effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996; 93: 1826-35.
7. Koga N, Iwata Y. Pathological and angiographic regression of coronary atherosclerosis by LM-apheresis in a patient with familial hypercholesterolemia. Atherosclerosis 1991; 90: 9-21.
8. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: utrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993; 13: 1404-11.
9. Pearson AC, Peterson JW, Orsinelli DA, Guo R, Boudoulas H. Comparison of thickness and distensibility in the carotid artery and descending thoracic aorta: in vivo ultrasound assessment. Am Heart J 1996; 131: 655-62.
10. Friedewald W, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preoperative ultracentrifuge. Clin Chem 1972; 18: 499-502.
11. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intima plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
12. Crouse JR III, Byington RP, Bond MG et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAGH). Am J Cardiol 1995; 75: 455-59.
13. Igarashi K, Horimoto M, Takenaka T, Inoue H, Miyata S. Acute cholesterol lowering therapy with LDL-apheresis improves endothelial function of the coronary microcirculation in patients with hypercholesterolemia. Circulation 1995; 92: 1-452.
14. Tamai O, Matsuoka H, Nishida H et al. Single LDL-apheresis improves endothelium-dependent vasodilation. Jpn J Apheresis 1996; 15: S39.
15. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR III. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 1991; 11: 1786-94.
16. Blankenhorn DH, Selzer RH, Crawford DW et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery: Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993; 88: 20-28.
17. Mack WJ, Selzer RH, Hedis HN et al. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke 1993; 24: 1779-83.
18. Furberg CD, Adams BP Jr, Applegate WB et al. for the Asymptomatic Carotid Artery Progression Study (ACAPS) research group. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994; 90: 1679-87.
19. Groot E, Jukerna JW, Boven AJ et al. on behalf of the REGRESS study group. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. Am J Cardiol 1995; 76: 40-46C.
20. Salonen R, Nyyssonen K, Porkkala E et al. Kuopio Atherosclerosis Prevention Study (KAPS): a population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995; 92: 1758-64.
21. Hodis HN, Mack WJ, LaBree L et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized, controlled clinical trial. Ann Intern Med 1996; 124: 548-56.